glp 1 for ra Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds Consensus Recommendations on GLP-1 RA

Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR

(5.10) Adverse Reactions/Side Effects Most common (5%) and occurring more frequently than placebo in clinical trials: nausea, hypoglycemia, vomiting, diarrhea, feeling jittery, dizziness, headache, dyspepsia, constipation, asthenia

RWJBarnabas Health System in New Jersey, for example, stopped covering GLP-1s for weight loss, though it will still cover them for diabetes, another condition these drugs commonly treat

Combination injections are better than separate ones for these cases

This is one reason why proper storage and shipping practices are important parts of quality control